亚太地区人类白细胞抗原 (HLA) 检测市场预测至 2028 年 - 按产品和服务（试剂和耗材、仪器以及软件和服务）、技术（分子检测技术和非分子检测技术）划分的 COVID-19 影响和区域分析和最终用户（独立参考实验室、医院和移植中心等）
No. of Pages: 164 | Report Code: BMIRE00025758 | Category: Life Sciences
No. of Pages: 164 | Report Code: BMIRE00025758 | Category: Life Sciences
活体器官捐献和死者器官捐献（DCD）是两种类型的器官捐赠。由于慢性病病例的增加，对两种类型器官捐献的需求日益增加。此外，根据印度政府卫生和家庭福利部（MoHFW）的数据，每年有50万人因无法获得器官而死亡； 20万人死于肝脏疾病； 50,000 人死于心脏病。此外，还有15万人等待肾移植，但只有5000人获得肾移植。这些数字表明对器官捐献者的需求，远大于实际的捐献数量。世界其他国家也出现了类似的情况。为了平衡器官的需求和供给，一些国家的政府实施了各种策略来促进器官捐献。政府的此类举措正在为 HLA 检测市场参与者创造机会，因为器官捐献和移植程序的增加可能会推动对 HLA 检测的需求。
随着新的功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动亚太地区人类白细胞抗原 (HLA) 检测市场在预测期内实现显着的复合年增长率。
亚太地区人类白细胞抗原（HLA）检测市场分为产品和检测产品。服务、技术、最终用户和国家/地区。基于产品和服务，市场分为试剂和服务耗材、仪器、软件和服务。从技术上来看，亚太地区人类白细胞抗原（HLA）检测市场分为分子检测技术和非分子检测技术。分子检测技术细分为基于 PCR 的分子检测、基于测序的分子检测等。根据最终用户，市场分为独立参考实验室、医院和移植中心等。按国家/地区划分，亚太地区人类白细胞抗原 (HLA) 检测市场分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。
< h3>
Thermo FISHER SCIENTIFIC INC.；护理Dx；凯杰；照明公司； Bio-Rad 实验室公司； TBG诊断有限公司； F. 霍夫曼拉罗什有限公司；宝生物公司；和 Luminex Corporation 是亚太地区人类白细胞抗原 (HLA) 检测市场的主要公司之一。
Strategic insights for Asia Pacific Human Leukocyte Antigen (HLA) Testing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 154.35 Million |
| Market Size by 2028 | US$ 243.18 Million |
| Global CAGR (2022 - 2028) | 7.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 产品和服务
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Human Leukocyte Antigen (HLA) Testing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Human Leukocyte Antigen (HLA) Testing Market is valued at US$ 154.35 Million in 2022, it is projected to reach US$ 243.18 Million by 2028.
As per our report Asia Pacific Human Leukocyte Antigen (HLA) Testing Market, the market size is valued at US$ 154.35 Million in 2022, projecting it to reach US$ 243.18 Million by 2028. This translates to a CAGR of approximately 7.9% during the forecast period.
The Asia Pacific Human Leukocyte Antigen (HLA) Testing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Human Leukocyte Antigen (HLA) Testing Market report:
The Asia Pacific Human Leukocyte Antigen (HLA) Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Human Leukocyte Antigen (HLA) Testing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Human Leukocyte Antigen (HLA) Testing Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Human Leukocyte Antigen (HLA) Testing Market
